Takara Bio Dividend yield

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   JPY per share 
 Price  2,417.00
 Dividend  7.98
 Earnings  30.36
 Cash-flow  48.05
 Book value  537.11
 Equity  523.45

Takara Bio is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Takara Bio is a company from Japan, and his stocks are publicly traded.

Takara Bio paid a total dividend of 958 million JPY last year, for a market value of 290,040 millions (Market Cap 110,597 millions). Dividend per share of Takara Bio is 7.98 JPY, and his stock market price 2,417.00 JPY.

According to the chart below, where dividend yield is displayed, Takara Bio has a dividend yield of 0.33%, lower than the amount offered by both the market average and companies from Japan. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare Takara Bio dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Japan.

Dividend yield of Takara Bio

Takara Bio Dividend Payout

About the ability of Takara Bio to maintain his current dividend of JPY 7.98 per share, an amount that accounts for 0.33%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Takara Bio payout on ernings is currently 26.28%, which is lower than the market average and companies of Health Care industry, which are 41.09% and 30.00% respectively. Both figures lead us to believe that there is confidence that Takara Biocan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Takara Bio is JPY 48.05 per share, which is higher than the dividend per share paid by the company of JPY 7.98, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Takara Bio, compared againt world market average, Japan companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Takara Bio payout

Takara Bio Stock performance

Finally, last moth Takara Bio showed a return of 8.30% compared to a worldwide 10.27% average, and a 10.94% of Health Care firms. Over the last year, the company obtained a -0.60% versus a worldwide performance of a -13.38%. More detailed information can be seen in the following graph for Japan and Pharmaceuticals and Biotechnology firms.

Takara Bio stock and market return

Next companies

Takara Holdings. Japan. Consumer Goods.

Takashimaya. Japan. Consumer Services.

Take-Two Interactive Software. USA. Consumer Goods.

Takeda Pharm. Japan. Health Care.

TAL Education Group. China. Consumer Services.

Talaat Moustafa Grou. Egypt. Financials.

Previous companies

Taiyo Yuden. Japan. Industrials.

Taiyo Nippon Sanso. Japan. Basic Materials.

Taiwan Semiconductor. Taiwan. Technology.

Taiwan Secom. Taiwan. Industrials.

Taiwan Mobile. Taiwan. Telecommunications.

Taiwan High Speed Rail. Taiwan. Industrials.



All rights reserved

 information advertisement legal

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.